PRI:NYSEPrimerica, Inc. Analysis
Data as of 2026-04-25 - not real-time
$279.97
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Primerica (PRI) trades at $279.97, well below its DCF-derived fair value of $639, implying a ~5% upside from intrinsic valuation. The stock’s valuation metrics are attractive – a trailing P/E of 12x versus an industry average of 17x, a low beta of 0.63 and a 30‑day volatility of ~19% suggest modest market risk. Fundamentals are strong: 8% revenue growth, gross margin of 71%, operating margin of 31%, ROE of 32% and free cash flow exceeding $1.1 bn, while the dividend payout ratio sits at only 18%, supporting dividend sustainability. Technical signals are mixed: the 14‑day RSI at 71.8 signals an overbought condition, yet the MACD histogram remains positive and the MACD line sits above its signal, indicating lingering bullish momentum. The price is near the recent resistance of $283.75, with support around $244, and volume is stable.
Given the substantial valuation gap, solid cash generation, and manageable risk profile, PRI presents a compelling value opportunity, though short‑term caution is warranted due to overbought momentum.
Given the substantial valuation gap, solid cash generation, and manageable risk profile, PRI presents a compelling value opportunity, though short‑term caution is warranted due to overbought momentum.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI indicating overbought conditions
- Price approaching short‑term resistance
- Stable volume and low beta limiting downside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant undervaluation vs DCF and peers
- Strong cash flow and low payout ratio supporting dividend
- Consistent earnings growth and high ROE
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust business model serving middle‑income households
- Sustainable dividend backed by free cash flow
- Long‑term upside potential as market re‑rates the company
Key Metrics & Analysis
Financial Health
Revenue Growth8.00%
Profit Margin22.43%
P/E Ratio12.2
ROE31.93%
ROA4.46%
Debt/Equity77.92
P/B Ratio3.6
Op. Cash Flow$901.2M
Free Cash Flow$1.1B
Industry P/E17.3
Technical Analysis
TrendNeutral
RSI71.8
Support$244.20
Resistance$283.75
MA 20$265.15
MA 50$258.50
MA 200$262.62
MACDBullish
VolumeStable
Fear & Greed Index88.02
Valuation
Fair Value$638.71
Target Price$293.33
Upside/Downside4.77%
GradeUndervalued
TypeValue
Dividend Yield1.54%
Risk Assessment
Beta0.63
Volatility18.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.